🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to compare the efficacy of parsaclisib when com...
Status
Terminated
Location
Alaska Oncology and Hematology
Start Date
2021-05-24
Trial ID
NCT04551066
Treatments Being Tested
This is a randomized, multi-center, parallel-group, active-controlled, doub...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00394355
This is a 9 month randomised controlled clinical comparing the clinical eff...
Status
Completed
Location
Multiple Locations
Start Date
2014-07
Trial ID
NCT02461667
Treatments Being Tested
This is a randomized, multi-center, double-blind, double-dummy, placebo-con...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00383552
The objectives of this study are to determine the safety and efficacy in se...
Status
Completed
Location
Multiple Locations
Start Date
1993-08-23
Trial ID
NCT03855189
Treatments Being Tested
The purpose of the study is to compare the efficacy and safety of parsaclis...
Status
Terminated
Location
Sutter Health Alta Bates Summit Medical Center Absmc Alta Bates Summit Comprehensive Cancer Center
Start Date
2021-05-26
Trial ID
NCT04551053
Treatments Being Tested
The purpose of this trial is to evaluate whether treatment with pelabresib ...
Status
Recruiting
Location
Yale University School Of Medicine
Start Date
2026-06-08
Trial ID
NCT07357727
Treatments Being Tested
Patellofemoral pain syndrome is one of the most common musculoskeletal diso...
Status
Unknown
Location
Cabinet libéral - 12, rue du Puits
Start Date
2015-06
Trial ID
NCT02250144
Treatments Being Tested
This is a randomized, placebo-controlled, parallel-group, multi-site, doubl...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00383435
A Phase 3, randomized, blinded study comparing pelabresib (CPI-0610) and ru...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-04-09
Trial ID
NCT04603495
Treatments Being Tested